These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 21885264)
1. [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?]. Genuini M; Freihuber C; Girard I; de Montgolfier I; Kieffer F; Mitanchez D Arch Pediatr; 2011 Oct; 18(10):1084-6. PubMed ID: 21885264 [TBL] [Abstract][Full Text] [Related]
7. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation. Bachmeyer C; Mouchnino G; Thulliez P; Blum L J Infect; 2006 Feb; 52(2):e55-7. PubMed ID: 16043225 [TBL] [Abstract][Full Text] [Related]
9. [DRESS complicated by hemophagocytic lymphohistiocytosis in an infant treated for congenital toxoplasmosis]. Rioualen S; Dufau J; Flatres C; Lavenant P; Misery L; Roué JM Ann Dermatol Venereol; 2017 Dec; 144(12):784-787. PubMed ID: 28728858 [TBL] [Abstract][Full Text] [Related]
10. [Recommendations for the treatment of prenatal toxoplasma infection in the child. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Study Group]. Döhring-Schwerdtfeger E; Leichsenring M; Liefke U; Padelt H; Sitzmann FC; Stehr K; Zimmermann PH Klin Padiatr; 1995; 207(1):38-41. PubMed ID: 7885018 [No Abstract] [Full Text] [Related]
11. [Severe complications arising from the prescription of pyrimethamine for infants being treated for toxoplasmosis]. Elmalem J; Poulet B; Garnier R; Frelon JH; Castot A Therapie; 1985; 40(5):357-9. PubMed ID: 4095694 [No Abstract] [Full Text] [Related]
12. High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil. Carellos EVM; de Andrade JQ; Romanelli RMC; Tibúrcio JD; Januário JN; Vasconcelos-Santos DV; Figueiredo RM; de Andrade GMQ; Pediatr Infect Dis J; 2017 Dec; 36(12):1169-1176. PubMed ID: 28151845 [TBL] [Abstract][Full Text] [Related]
13. [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis]. Mubiayi N; Coutty N; Detourmignies L; Le Goueff F; Decocq J; Delahousse G Presse Med; 2004 Aug; 33(14 Pt 1):930-3. PubMed ID: 15509046 [TBL] [Abstract][Full Text] [Related]
14. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. Kaye A J Pediatr Health Care; 2011; 25(6):355-64. PubMed ID: 22018426 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases]. Kieffer F; Thulliez P; Brézin A; Nobre R; Romand S; Yi-Gallimard E; Voyer M; Magny JF Arch Pediatr; 2002 Jan; 9(1):7-13. PubMed ID: 11865553 [TBL] [Abstract][Full Text] [Related]
16. [Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow]. Weissbach G Z Arztl Fortbild (Jena); 1965 Jan; 59(1):10-22. PubMed ID: 5885819 [No Abstract] [Full Text] [Related]
17. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination. Villena I; Quereux C; Pinon JM Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662 [No Abstract] [Full Text] [Related]
18. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)]. Couvreur J; Nottin N; Desmonts G Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550 [No Abstract] [Full Text] [Related]
19. [Adverse effects of combined toxoplasmosis therapy with daraprim and sulfonamides]. Krüger E; Gerschke G Padiatr Grenzgeb; 1969; 8(1):39-48. PubMed ID: 5382580 [No Abstract] [Full Text] [Related]